• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野生型胃肠道间质瘤患者的人口统计学、临床病理学特征和结局:全国队列分析。

Patient demographics, clinicopathologic features, and outcomes in wild-type gastrointestinal stromal tumor: a national cohort analysis.

机构信息

Surgical Oncology Program, National Cancer Institute, Bethesda, MD, USA.

Department of Surgery, The Mount Sinai Hospital, New York, NY, USA.

出版信息

Sci Rep. 2022 Apr 6;12(1):5774. doi: 10.1038/s41598-022-09745-1.

DOI:10.1038/s41598-022-09745-1
PMID:35388076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8987058/
Abstract

Wild-type KIT and PDGFRA gastrointestinal stromal tumors (GIST) are rare tumors with limited treatment options. We sought to determine the clinicopathologic features of wild-type GIST and identify factors that influence overall survival (OS) using a large national database. Retrospective evaluation of patients with wild-type GIST in the National Cancer Database (NCDB) was performed. Demographic, clinicopathologic, and treatment data were analyzed. Features associated with OS were investigated using Kaplan-Meier analysis and Cox proportional hazards model. 244 patients with median diagnosis age of 59 years (95% CI 57-63) were identified. The stomach was the most common primary site (57%) followed by the small intestine (35%). Surgical resection was performed on 85% of patients and 53% of patients received systemic therapy. Factors associated with decreased OS on multivariable analysis included small intestine primary (HR 2.72, 95% CI 1.13-6.69, P = 0.026) and > 5 mitoses per 50 HPF (HR 4.77, 95% CI 1.86-13.2, P = 0.001). Wild-type GISTs may be identified in older patients, with most arising in the stomach and small bowel. Surgery remains the principal treatment modality. Small intestine primary site and high mitotic count were associated with abbreviated OS.

摘要

野生型 KIT 和 PDGFRA 胃肠道间质瘤(GIST)是罕见的肿瘤,治疗选择有限。我们旨在通过大型国家数据库确定野生型 GIST 的临床病理特征,并确定影响总生存(OS)的因素。对国家癌症数据库(NCDB)中野生型 GIST 患者进行回顾性评估。分析了人口统计学、临床病理和治疗数据。使用 Kaplan-Meier 分析和 Cox 比例风险模型研究与 OS 相关的特征。确定了 244 名中位诊断年龄为 59 岁(95%CI 57-63)的患者。最常见的原发部位是胃(57%),其次是小肠(35%)。85%的患者接受了手术切除,53%的患者接受了系统治疗。多变量分析显示,OS 降低的相关因素包括小肠原发(HR 2.72,95%CI 1.13-6.69,P=0.026)和每 50HPF 超过 5 个有丝分裂(HR 4.77,95%CI 1.86-13.2,P=0.001)。野生型 GIST 可能发生在年龄较大的患者中,大多数发生在胃和小肠。手术仍然是主要的治疗方式。小肠原发部位和高有丝分裂计数与 OS 缩短相关。

相似文献

1
Patient demographics, clinicopathologic features, and outcomes in wild-type gastrointestinal stromal tumor: a national cohort analysis.野生型胃肠道间质瘤患者的人口统计学、临床病理学特征和结局:全国队列分析。
Sci Rep. 2022 Apr 6;12(1):5774. doi: 10.1038/s41598-022-09745-1.
2
Comparing the long-term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: An analysis of the National Cancer Database.胃和小肠胃肠道间质瘤患者的长期预后比较:一项基于国家癌症数据库的分析
J Surg Oncol. 2018 Sep;118(3):486-492. doi: 10.1002/jso.25172. Epub 2018 Aug 21.
3
Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.伊马替尼初治的胃和小肠胃肠道间质瘤(GIST)成人患者中 c-KIT 和 PDGFR-α 基因突变:与肿瘤生物学危险度特征和长期预后的关系。
Clin Transl Oncol. 2012 Aug;14(8):619-29. doi: 10.1007/s12094-012-0851-x. Epub 2012 Jul 18.
4
Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.表现为网膜肿块的胃肠道间质瘤——95例临床病理分析
Am J Surg Pathol. 2009 Sep;33(9):1267-75. doi: 10.1097/PAS.0b013e3181a13e99.
5
Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.小肠胃肠道间质瘤(GISTs)的外科治疗及预后分析:在甲磺酸伊马替尼时代之前
BMC Gastroenterol. 2006 Oct 24;6:29. doi: 10.1186/1471-230X-6-29.
6
Surgical Management of Adolescents and Young Adults With Gastrointestinal Stromal Tumors: A US Population-Based Analysis.青少年和青年胃肠道间质瘤的外科治疗:一项基于美国人群的分析。
JAMA Surg. 2017 May 1;152(5):443-451. doi: 10.1001/jamasurg.2016.5047.
7
Laparoscopic versus open resection of gastrointestinal stromal tumors: survival outcomes from the NCDB.腹腔镜与开放手术切除胃肠道间质瘤:NCDB 的生存结果。
Surg Endosc. 2019 Mar;33(3):923-932. doi: 10.1007/s00464-018-6393-8. Epub 2018 Aug 31.
8
Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.重新审视一个教条:小肠和胃间质瘤患者的生存率相似。一项基于人群的倾向评分SEER分析。
Gastric Cancer. 2017 Jan;20(1):49-60. doi: 10.1007/s10120-015-0571-3. Epub 2015 Dec 9.
9
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.野生型胃肠道间质瘤的外科治疗:来自美国国立卫生研究院儿科与野生型胃肠道间质瘤诊所的报告
J Clin Oncol. 2017 Feb 10;35(5):523-528. doi: 10.1200/JCO.2016.68.6733. Epub 2016 Dec 28.
10
[Clinicopathological features and prognosis of gastrointestinal stromal tumors with gene "homozygous mutation": a multicenter retrospective cohort study].基因“纯合突变”胃肠道间质瘤的临床病理特征及预后:一项多中心回顾性队列研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Sep 25;24(9):804-813. doi: 10.3760/cma.j.cn.441530-20210720-00293.

引用本文的文献

1
Artificial Intelligence-Based Diagnosis of Gastric Mesenchymal Tumors Using Digital Endosonography Image Analysis.基于人工智能的胃间质瘤数字超声内镜图像分析诊断
J Clin Med. 2024 Jun 26;13(13):3725. doi: 10.3390/jcm13133725.
2
Identification and validation of protein biomarkers for predicting gastrointestinal stromal tumor recurrence.用于预测胃肠道间质瘤复发的蛋白质生物标志物的鉴定与验证
Comput Struct Biotechnol J. 2024 Feb 22;23:1065-1075. doi: 10.1016/j.csbj.2024.02.017. eCollection 2024 Dec.
3
Impact of Tumor Size and Management on Survival in Small Gastric Gastrointestinal Stromal Tumors.

本文引用的文献

1
KIT Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor.KIT 细胞介导胃肠道间质瘤对伊马替尼的耐药性。
Mol Cancer Ther. 2021 Oct;20(10):2035-2048. doi: 10.1158/1535-7163.MCT-20-0973. Epub 2021 Aug 10.
2
Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug Sensitivity.胃胃肠道间质瘤(GIST)的位置可预测肿瘤突变谱和药物敏感性。
Clin Cancer Res. 2021 Oct 1;27(19):5334-5342. doi: 10.1158/1078-0432.CCR-21-1221.
3
Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver Mutations.
肿瘤大小和治疗方法对小胃胃肠间质瘤患者生存的影响。
J Gastrointest Surg. 2023 Oct;27(10):2076-2084. doi: 10.1007/s11605-023-05779-6. Epub 2023 Jul 11.
同步发生但基因组不同的胃肠道间质瘤为肿瘤驱动基因突变的精准靶向提供了新见解。
JCO Precis Oncol. 2021 Mar 19;5. doi: 10.1200/PO.20.00384. eCollection 2021.
4
Characteristics and prognosis of jejunoileal gastrointestinal stromal tumours (GISTs) in the era of imatinib: a comparative study with gastric GISTs.在伊马替尼时代的空肠回肠胃肠道间质瘤(GISTs)的特征和预后:与胃 GISTs 的对比研究。
Clin Transl Oncol. 2021 Jul;23(7):1368-1376. doi: 10.1007/s12094-020-02528-y. Epub 2021 Jan 30.
5
Gastrointestinal Stromal Tumor: Challenges and Opportunities for a New Decade.胃肠道间质瘤:新十年的挑战与机遇
Clin Cancer Res. 2020 Oct 1;26(19):5078-5085. doi: 10.1158/1078-0432.CCR-20-1706. Epub 2020 Jun 29.
6
Gastrointestinal Stromal Tumours (GIST) in Young Adult (18-40 Years) Patients: A Report from the Dutch GIST Registry.年轻成人(18 - 40岁)患者的胃肠道间质瘤(GIST):来自荷兰GIST注册中心的报告
Cancers (Basel). 2020 Mar 20;12(3):730. doi: 10.3390/cancers12030730.
7
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.晚期胃肠间质瘤伊马替尼长期疗效与下一代测序结果的相关性:SWOG 多中心临床试验 S0033 分析
JAMA Oncol. 2017 Jul 1;3(7):944-952. doi: 10.1001/jamaoncol.2016.6728.
8
Surgical Management of Adolescents and Young Adults With Gastrointestinal Stromal Tumors: A US Population-Based Analysis.青少年和青年胃肠道间质瘤的外科治疗:一项基于美国人群的分析。
JAMA Surg. 2017 May 1;152(5):443-451. doi: 10.1001/jamasurg.2016.5047.
9
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.野生型胃肠道间质瘤的外科治疗:来自美国国立卫生研究院儿科与野生型胃肠道间质瘤诊所的报告
J Clin Oncol. 2017 Feb 10;35(5):523-528. doi: 10.1200/JCO.2016.68.6733. Epub 2016 Dec 28.
10
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.KIT/PDGFRA 野生型胃肠道间质瘤的分子亚型:来自美国国立卫生研究院胃肠道间质瘤临床中心的报告。
JAMA Oncol. 2016 Jul 1;2(7):922-8. doi: 10.1001/jamaoncol.2016.0256.